Teladoc Health launches remote monitoring and ambient AI features for virtual care platform

Teladoc Health is expanding its virtual care platform by launching SoloScribe, an ambient AI clinical documentation tool, and SoloVitals, a contactless remote patient monitoring feature. These integrations aim to reduce platform fatigue for struggling health systems as Teladoc seeks to recover from a $200.3 million net loss in 2025. Meanwhile, the broader digital health landscape is shifting toward automated clinical tools, highlighted by Utah launching a pioneering AI-prescribing pilot with Nolla Health and Bask Health offering rapid-deployment infrastructure for direct-to-consumer digital clinics.

Teladoc's platform expansion strategy

• ▪Joby McKenzie of Teladoc Health stated that integrating multiple clinical tools into a single platform helps health systems reduce the operational pressure of navigating fragmented vendors.
• ▪Teladoc Health is expanding its platform features to drive growth and attract investment amid financial struggles, including a $200.3 million net loss in 2025 and a lowered 2026 revenue outlook.
• ▪Teladoc Health announced the addition of new artificial intelligence capabilities, including an AI scribe and contactless remote patient monitoring, to its virtual care platform on October 7, 2026.

Teladoc's SoloScribe documentation tool

• ▪The Teladoc Health SoloScribe tool is currently available to users, whereas the SoloVitals monitoring feature is only accessible to select customers in a private preview.
• ▪The Teladoc Health SoloScribe feature is an ambient AI documentation tool that records and transcribes clinical encounters to generate clinical notes for both in-person and virtual patient visits.

Teladoc's SoloVitals monitoring feature

• ▪Teladoc Health expects to release its contactless remote patient monitoring feature, SoloVitals, broadly to customers in December 2026.
• ▪The Teladoc Health SoloVitals feature uses camera-equipped Solo devices to capture facial skin color and analyze blood volume changes optically to track patient heart and respiratory rates without physical contact.

Utah's AI-Prescribing pilots and regulatory concerns

• ▪The Nolla Health pilot program requires the first 100 AI-generated prescriptions to be independently approved by two licensed physicians before reaching patients.
• ▪Utah approved a pilot program launched by Nolla Health on October 5, 2026, allowing an AI system to issue initial medication prescriptions for acne treatment without a doctor visit.
• ▪Medical regulators and physician groups argue that automated questionnaires and AI systems may fail to capture complex clinical factors like underlying health conditions and drug interactions.
• ▪The Utah Medical Licensing Board formally urged state officials in April 2026 to suspend an earlier AI-prescribing pilot by Doctronic, citing critical safety concerns regarding automated clinical decisions.

Bask Health's telehealth infrastructure platform

• ▪Bask Health operates as a white-label telehealth infrastructure platform that allows brands, creators, and entrepreneurs to launch compliant direct-to-consumer digital clinics.
• ▪Bask Health claims its platform provides turnkey access to physician networks, compliance infrastructure, and multi-pharmacy fulfillment support, enabling setup in 24 to 48 hours.

Debatable claims

• ▪AI systems should be permitted to issue initial prescriptions for low-risk conditions
• ▪A single integrated virtual care platform is superior to using multiple specialized health vendors
• ▪Contactless camera-based vital sign monitoring is reliable enough for clinical patient care